학술논문

A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
Document Type
Article
Source
In Blood Advances 9 April 2024 8(7):1612-1620
Subject
Clinical Trials and Observations
Language
ISSN
2473-9529